Retatrutide + Tesamorelin Bundle
The Retatrutide + Tesamorelin Bundle is sold in Australia by Australian Research Peptides as one 10 mg vial of each peptide, running two different routes to the same target. Retatrutide acts at the GIP, GLP-1 and glucagon receptors, blunting appetite and pushing stored fat into use; Tesamorelin works a step further back, prompting the pituitary to release its own growth hormone — the mechanism behind the drops in deep abdominal fat its trials measured. Twenty syringes and a 3 mL water vial come with them, and the kit posts to every state and territory. For in vitro research purposes only.
Bundles · Lyophilised Powder · Batch-tested · SKU ARP-BUNDLE-RETTES
$290.99
Includes Retatrutide 10 mg + Tesamorelin 10 mg + BAC Water 3 mL + Insulin Syringes 20 Pack
$320.96bought separatelySave $29.97 (9.3%)Free shipping
Free Standard tracked post — this bundle clears the $199 threshold on its own, with nothing added.
1
Presentation
2 vials + water + syringes
Grade
High-Purity Research Grade
Form
Lyophilised Powder
Category
Bundles
Same-day dispatch on business-day orders placed before 12pm AEST, Mon–Fri
Tracked shipping Australia-wide ·typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. Any amounts shown are reported from published studies, with the species or trial population named. ARP gives no dosing, medical or therapeutic guidance of its own.
Retatrutide + Tesamorelin Bundle · 2 vials + water + syringes
$290.99
Frequently Bought Together
About Retatrutide + Tesamorelin Bundle
The Retatrutide + Tesamorelin Bundle is a four-item kit: one 10 mg Retatrutide vial, one 10 mg Tesamorelin vial, one 3 mL vial of bacteriostatic water and one pack of twenty insulin syringes. The two peptides are supplied in separate sealed vials and are not combined, so this is two single-compound listings and two consumables bought on one order.
The pairing is a catalogue relationship rather than a formulation. Retatrutide and Tesamorelin are unrelated molecules that reach the same research field from different directions, and neither one is a component of the other, which is why the kit supplies twice as much glass rather than one shared vial. Both arrive freeze-dried, so a single 3 mL diluent vial and one twenty-pack of syringes cover the pair — buying the two peptides on their own leaves both of those still to order.
The compound pages carry the substance for each. Retatrutide is a 39-amino-acid peptide developed under the code LY3437943 and reaches three receptors at once; Tesamorelin is a full-length analogue of growth-hormone-releasing hormone carrying a hexenoyl group at one end. What each has been studied in, and the papers supporting it, are on the Retatrutide and Tesamorelin listings. This page states what is in the box and how the box is handled.
Content reviewed
Further reading: Retatrutide Price in Australia
Retatrutide + Tesamorelin Bundle specifications, storage and shipping
- Compound: Retatrutide + Tesamorelin Bundle
- Appearance: Two vials of lyophilised powder, one vial of clear colourless solution, twenty capped syringes
- Sizes & SKUs: 2 vials + water + syringes (ARP-BUNDLE-RETTES)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: High-purity research grade
- Purity verification: HPLC-assayed on every batch to a minimum of 99% purity — the measured result for your batch is stated on its Certificate of Analysis
- Identity confirmation: Mass spectrometry
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
Every batch undergoes HPLC purity analysis and mass-spectrometry identity confirmation. No laboratory report is published for this line yet. The COA library lists every product and strength, and says which reports are available.
Business-day orders before 12pm AEST are dispatched the same day with tracked, discreet shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about Retatrutide + Tesamorelin Bundle
Australian Research Peptides answers the key questions about the Retatrutide + Tesamorelin Bundle, including exact contents, live price and availability, Australian delivery, handling, component testing and comparisons with buying the items separately. Start with the quick answers, then browse every existing question by topic.
Buying, price and availability
Retatrutide and Tesamorelin ship together from Australian Research Peptides on one kit listing, SKU ARP-BUNDLE-RETTES, holding a 10 mg vial of each with syringes and a 3 mL water vial. Orders lodged on a weekday before 12pm AEST go out that afternoon, tracked, and Express Post covers every state and territory. Nothing crosses a border to reach you — the parcel starts in Australia.
Australian Research Peptides sells the pair online as the Retatrutide + Tesamorelin Bundle under stock code BNDRETTES, which puts both compounds and both consumables on one line. The two payment routes are PayID and bank transfer, so a card is never used. The kit is made up and lodged in Sydney, meaning a domestic order goes nowhere near customs.
Australian Research Peptides builds this kit, and Chemist Warehouse is no exception to the rule that pharmacies do not. Neither retatrutide nor tesamorelin holds an Australian registration, so a retail pharmacy has no route to supply either compound and none at all to supply them together. ARP dispatches both vials plus the water and syringes from Sydney.
Identity, names and exact format
The Retatrutide + Tesamorelin Bundle contains two peptide vials at 10 mg each — Retatrutide and Tesamorelin — plus twenty insulin syringes and a single 3 mL bacteriostatic water vial. Both peptide vials use the same 10 mg strength.
The Retatrutide + Tesamorelin Bundle includes the two peptide vials plus the bacteriostatic water and syringes, which is what a bench workflow needs beyond ordinary laboratory equipment. That 3 mL vial is what reconstitutes both peptides. Nothing further is supplied — no diluent other than the water vial, and no glassware, storage or measuring equipment.
The Retatrutide + Tesamorelin Bundle contains the 10 mg Tesamorelin vial, which is the only strength Australian Research Peptides lists for that compound, so there is nothing to choose between. The bundle and the standalone Tesamorelin listing supply the identical item. What the bundle adds beside it is the Retatrutide vial, the bacteriostatic water and the twenty syringes.
One 3 mL bacteriostatic water vial ships in the Retatrutide + Tesamorelin Bundle for two 10 mg peptide vials, which divides more neatly here than in the other two kits because both vials hold the same amount. Half each, 1.5 mL, gives about 6.67 mg per mL in both. One millilitre each gives 10 mg per mL and leaves 1 mL spare. Divide milligrams by millilitres for anything else.
Australian Research Peptides identifies this kit with catalogue code BNDRETTES; the bundle itself has no scientific synonym. Retatrutide is indexed under the development code LY3437943. Tesamorelin carries the development code TH9507, also written TH-9507, and is described as the (3E)-hex-3-enoyl derivative of hGRF(1-44) amide.
Handling, storage and measurements
Both peptide vials in the Retatrutide + Tesamorelin Bundle will look close to empty, and that is expected of 10 mg of freeze-dried solid: it dries to a wafer or to a haze on the glass that direct light hides. Tilting each against something dark reveals it. Batch analysis records weight, not visible bulk, which is why two vials that look bare are not two vials that are.
Each item in the Retatrutide + Tesamorelin Bundle follows the storage printed on its own label, since putting four things in one parcel changes nothing about how any of them keeps. Both sealed peptide vials want cold, dry and dark; the bacteriostatic water and the syringes want no more than a cupboard. Reconstituted solution is a separate question and is answered on each compound's own listing.
Retatrutide and Tesamorelin are reconstituted in their own vials and are never mixed into one, which is why the kit supplies two vials rather than a single combined one. Run bacteriostatic water down the inside wall of each, swirl until the solid has gone into solution, and do not shake. Both are 10 mg vials, so the same volume gives the same concentration in each.
Testing and batch documents
The Retatrutide and Tesamorelin vials cannot come from the same batch because they are different compounds manufactured and HPLC-tested separately. A bundle has no certificate of its own. A matching certificate is currently published for the 10 mg Retatrutide vial. Open the Retatrutide 10 mg certificate. A matching certificate is currently published for the 10 mg Tesamorelin vial. Open the Tesamorelin 10 mg certificate.
Ordering, payment and Australian delivery
Free Standard tracked post applies to this pairing with no help from the rest of the basket. Express Post is a separate waiver at a higher figure, and of the three kits Australian Research Peptides assembles this one comes closest without quite reaching it. Adding a water vial or a syringe pack is the usual way an order closes that gap.
The Retatrutide + Tesamorelin Bundle moves entirely within Australia as one parcel, so there is no border stage in its journey. Australia Post's standard tracked service usually takes 2-5 business days between capital cities. Express Post shortens that by an amount that depends on the destination: two business days at the outside for the ACT, NSW, Victoria and South Australia, three for Queensland, four for WA, Tasmania and the NT. Add time for regional addresses.
The Retatrutide + Tesamorelin Bundle is paid for by PayID or by bank transfer, the same two routes Australian Research Peptides uses for every line it sells, and combining two compounds on one order does not add a third. Cards, wallets, instalment accounts and cryptocurrency are all unavailable. A single transfer settles the whole kit, because it is one catalogue line and not four.
Access, approval and sport questions
Neither peptide in the Retatrutide + Tesamorelin Bundle is approved by the TGA for therapeutic use in Australia, so the kit is not either. The two sit differently, though: retatrutide is investigational and unapproved anywhere in the world, while tesamorelin is an approved medicine in some overseas markets and not here. Australian Research Peptides supplies both as laboratory research material rather than as medicines.
The Retatrutide + Tesamorelin Bundle carries no FDA approval as a kit, because approval is granted to a medicine for an indication and never to a package of items. The two compounds also differ here, and the difference is worth knowing: tesamorelin has held a US approval since 2010 for a specific patient group, while retatrutide has none. Neither is approved in Australia, and research-grade material is outside both positions.
The Retatrutide + Tesamorelin Bundle is banned in sport on two independent grounds. Tesamorelin is written by name among the GHRH analogues under S2.2; retatrutide, investigational and unlicensed everywhere, is captured by S0. Neither restriction pauses out of season. Australian athletes come under Sport Integrity Australia, where a sample's contents decide the outcome.
Importing either compound personally puts the obligation on the importer, since the TGA controls what unapproved goods may enter and Border Force enforces it on arrival. An order placed here does not raise the question at all, because the kit is assembled and posted inside Australia and no parcel crosses a border. Anyone importing on their own account should start with the TGA's guidance.